N
AMED

Natixis’s Amedisys AMED Stock Holding History

Natixis’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,887
Closed -$5.01M – 1064
2025
Q2 		$5.01M Buy
50,887
+30,522
+150% +$2.89M 0.02% 347
2025
Q1 		$1.89M Sell
20,365
-530
-3% -$48.9K 0.01% 440
2024
Q4 		$1.9M Sell
20,895
-106,123
-84% -$9.75M 0.01% 480
2024
Q3 		$12.3M Buy
127,018
+62,775
+98% +$6.13M 0.07% 192
2024
Q2 		$5.9M Sell
64,243
-41,975
-40% -$3.89M 0.03% 277
2024
Q1 		$9.79M Sell
106,218
-15,984
-13% -$1.5M 0.05% 236
2023
Q4 		$11.6M Buy
122,202
+13,259
+12% +$1.24M 0.08% 193
2023
Q3 		$10.2M Buy
108,943
+76,393
+235% +$7.06M 0.08% 197
2023
Q2 		$2.98M Buy
+32,550
New +$2.67M 0.02% 365
2023
Q1 		– Sell
-11,000
Closed -$919K – 981
2022
Q4 		$919K Buy
+11,000
New +$992K 0.01% 643
2019
Q4 		– Sell
-2,170
Closed -$284K – 830
2019
Q3 		$284K Buy
+2,170
New +$282K ﹤0.01% 739
2019
Q2 		– Sell
-2,124
Closed -$255K – 732
2019
Q1 		$255K Buy
+2,124
New +$267K ﹤0.01% 742
2017
Q4 		– Sell
-4,460
Closed -$250K – 838
2017
Q3 		$250K Buy
+4,460
New +$236K ﹤0.01% 996

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Natixis's AMED Position: Q3 2025 in Review

Natixis sold out of Amedisys (AMED) in Q3 2025, closing a stake of 50,887 shares — an estimated $5.01M sold.

Natixis first reported a position in AMED in Q3 2017 and held it in 13 quarters. The position peaked at $12.3M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Natixis reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 50,887 Amedisys shares in Q3 2025, an estimated $5.01M.
  • Natixis first reported a position in Amedisys in Q3 2017 and held it in 13 quarters.
  • Natixis's Amedisys position peaked at $12.3M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.